Takeda Pharmaceutical Company Limited (LON: 0A87)
London
· Delayed Price · Currency is GBP · Price in USD 13.41
-0.34 (-2.47%)
At close: Jan 31, 2025
Takeda Pharmaceutical Company Revenue
Takeda Pharmaceutical Company had revenue of 1.14T JPY in the quarter ending December 31, 2024, with 2.96% growth. This brings the company's revenue in the last twelve months to 4.58T, up 9.83% year-over-year. In the fiscal year ending March 31, 2024, Takeda Pharmaceutical Company had annual revenue of 4.26T with 5.87% growth.
Revenue (ttm)
4,579.02B JPY
Revenue Growth
+9.83%
P/S Ratio
n/a
Revenue / Employee
92.92M JPY
Employees
49,281
Market Cap
34.65B GBP
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 4,263.76B | 236.28B | 5.87% |
| Mar 31, 2023 | 4,027.48B | 458.47B | 12.85% |
| Mar 31, 2022 | 3,569.01B | 371.19B | 11.61% |
| Mar 31, 2021 | 3,197.81B | -93.38B | -2.84% |
| Mar 31, 2020 | 3,291.19B | 1,193.96B | 56.93% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| Shell | 227.10B |
| HSBC Holdings | 43.25B |
| Unilever | 51.12B |
| Rio Tinto Group | 42.87B |
| RELX PLC | 9.30B |
| British American Tobacco p.l.c. | 26.18B |
| BP p.l.c. | 144.69B |